BARRY BRATCHER

BARRY BRATCHER

Acting CEO and Cofounder

Mr. Barry Bratcher serves as the Acting CEO of KBio and brings more than 30 years of experience developing and running cGMP processes for expressing and purifying recombinant proteins and plants. He oversaw the 2014-2016 execution of more than 60 consecutive cGMP runs of the zMapp anti-Ebola monoclonal antibody.

KBio Inc is a wholly owned subsidiary of KBio Holdings Limited, a BAT Group company.

Scroll to Top